claim: de novo design of ace2 protein decoys to neutralize sars-cov-2
evidence_1: the designed proteins act as decoys that block cellular entry and aim to be resilient to viral mutational escape.", "future refinements to our strategy can enable the rapid development of other therapeutic de novo protein decoys, not limited to neutralizing viruses, but to combat any agent that explicitly interacts with cell surface proteins to cause disease.")